Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced an upcoming presentation of preclinical data on the ...
6h
Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...
Discover Magazine on MSN1d
New Drug Delivery System Could Reduce GLP-1 Shortage and Make It More EfficientLearn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.
Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and ...
Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients ...
Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval
On , US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical-an innovative biopharmaceutical company incubated by Beijing Hotgen Biotech Co., ...
A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...
Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that ...
The author of the ‘Leonard List’ that highlights emerging hematologic research to be presented at annual ASH meetings is also ...
It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback